Login to Your Account



Nuron Biotech Inks Vaccine License with Mitsubishi Tanabe

By Marie Powers
Staff Writer

Friday, January 13, 2012
Privately held Nuron Biotech Inc. hooked a big fish for its first licensing deal. The Exton, Pa.-based company signed an agreement with Mitsubishi Tanabe Pharma Corp. (MTPC), of Osaka, Japan, to commercialize its HibTiter vaccine (Haemophilus b conjugate vaccine [diphtheria CRM197 protein conjugate]) in Japan, both as a single entity and for combination product use.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription